Alzheimer's Prevention Alzheimer's Treatment Galantamine Vascular Dementia Alzheimer's Treatment Effective at Modulating Cytokine Proteins and Brain Inflammation Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Alternative Medicine Review, June, 2008 by Parris M. Kidd, PhD, The University of California at Berkeley Alzheimer's disease is now the sixth-leading cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics. The CDC estimates that 72,914 Americans died of Alzheimer's disease in 2006. With an unprecedented historic population shift of 78 million aging baby boomers in the country and this disease poised to strike 10 million boomers - it is clear this escalating epidemic must be addressed now. -Alzheimer's Association The Memeron formula expands upon the cholinergic hypothesis of Alzheimer's disease. Memeron works specifically on the acetylcholine neurotransmitter system, as well as, build new brain cells, reduce inflammation, and remove amyloid beta plaques. Acetylcholinesterase inhibitors on the market today such as Aricept (donepezil), Razadyne (galantamine alone), and Exelon (Rivastigmine) just inhibit the breakdown of acetylcholine, Memeron provides additional acetylcholine to the brain through acetylcholine synthesis utilizing Alpha GPC (choline alfoscerate) as a precursor. Memeron does two tasks simultaneously- prevent the breakdown of acetylcholine AND supply additional acetylcholine for memory functions. Its not enough simply to slow down the breakdown of acetylcholine. You have to build new neurons, establish new connections between brain regions, reduce brain inflammation, and remove amyloid beta plaques. Memeron is perhaps the best treatment currently available to alleviate symptoms and help reverse disease pathology.
